Explore News By Topic
10/12/2017
PCF-Funded Researchers at the Cleveland Clinic Reveal Biomarker for Guiding Prostate Cancer Treatment
October 12, 2017, Cleveland: Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit... Read More
10/05/2017
Prostate Cancer Foundation Announces 2017 PCF Challenge Awards to Accelerate the Development of New Treatments for Advanced Prostate Cancer
WASHINGTON, D.C., October 5, 2017 – The Prostate Cancer Foundation (PCF) today announced awards totaling $7.5 million to fund new 2017 PCF Challenge Awards supporting international, cross-disciplinary teams of investigators conducting pioneering research into critical, unmet medical needs in areas that have the highest potential for impacting and extending lives... Read More
09/18/2017
New Biomarker Predicts Metastatic Prostate Cancers
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and life-threatening. Currently, doctors have limited ability to predict which newly diagnosed... Read More
09/14/2017
The Prostate Cancer Foundation, in Collaboration With World’s Leading Researchers, Publish Standard Setting Comprehensive Patient Guide
Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families LOS ANGELES, CA, September 14, 2017 – The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer... Read More
09/05/2017
Dax Shepard, Dr. Drew Pinsky and Rob Riggle Join the Prostate Cancer Foundation with an Urgent Plea to ‘Save the Males’ for Prostate Cancer Awareness Month
LOS ANGELES, CA, September 5, 2017 – – In recognition of Prostate Cancer Awareness Month, Many vs Cancer (MvC) today launched its new campaign, Save the Males, with support from Dax Shepard, Dr. Drew Pinsky and Rob Riggle. This new campaign from the Prostate Cancer Foundation’s MvC initiative aims to... Read More
08/23/2017
Prostate Cancer Foundation Announces Six 2017 Challenge Awards Funded in Partnership with the Movember Foundation
SANTA MONICA, CA, August 23, 2017 – The Prostate Cancer Foundation (PCF) today announced six new Challenge Awards funded in partnership with the Movember Foundation. These multi-year awards support cross-disciplinary teams of investigators conducting pioneering research to advance treatments and cures for prostate cancer. PCF received a donation of $5.4... Read More
08/10/2017
Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs
Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More
08/04/2017
Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment
Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More
08/02/2017
Comprehensive sequencing program shows promise of precision medicine for advanced cancer
ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More
07/10/2017
Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients
SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating the delivery of life-extending and life-saving therapies for men living with prostate cancer. The YI Awards provide three years of... Read More